Northern Lipids Inc (NLI) is a Contract Research Organization (CRO) that was established in 1991 to provide products and services to biotechnology companies engaged in the development of pharmaceutical products. We specialize in providing services to companies that are actively developing lipid-based (liposome, emulsion, micelle) drug delivery systems.
NLI has experience working with virtually all classes of pharmaceuticals, ranging from small molecules to peptides, proteins, DNA, antisense and siRNA. Our team is recognised for making a number of significant contributions to current practices and underlying concepts associated with the formulation of liposome-based pharmaceuticals. The company offers a range of CMC (Chemistry Manufacturing Controls) related services:
Small and large-scale LIPEXÔ equipment for preparing liposomes;
Lead prototype identification;
Manufacturing process development & scale-up;
Analytical method development & validation;
Clinical trial manufacturing under cGMP
Stability Programs Our extensive North American and International client-base speaks to our ability to meet the needs of our clients. Our research-driven and client-focused business approach makes us an ideal strategic partner for companies that are developing parenteral products for the rational treatment of diseases or conditions.
